title: Treatment to prevent hepatitis B virus reactivation in patients with lymphoma receiving chemotherapy--reply.
authors: Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
authors: Tongyu
authors: T
authors: Lin
authors: Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
authors: He
authors: H
authors: Huang
authors: Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
authors: Xueying
authors: X
authors: Li
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D006147:Guanine / Q000031:analogs & derivatives*; D006509:Hepatitis B / Q000517:prevention & control*; D006514:Hepatitis B Surface Antigens / Q000097:blood*; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male
chemical_list: D000998:Antiviral Agents; D006514:Hepatitis B Surface Antigens; D019259:Lamivudine; D006147:Guanine